Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/331
DC FieldValueLanguage
dc.contributor.authorChung E.L.T.en_US
dc.contributor.authorKamalludin M.H.en_US
dc.contributor.authorJesse F.F.A.en_US
dc.contributor.authorReduan, Farhan Hanifen_US
dc.contributor.authorLing L.W.en_US
dc.contributor.authorMahzan N.M.en_US
dc.contributor.authorHenipah N.N.M.M.A.en_US
dc.contributor.authorLoh T.C.en_US
dc.contributor.authorIdrus Z.en_US
dc.date.accessioned2021-01-17T02:55:52Z-
dc.date.available2021-01-17T02:55:52Z-
dc.date.issued2020-04-
dc.identifier.issn16185641-
dc.identifier.urihttp://hdl.handle.net/123456789/331-
dc.descriptionScopusen_US
dc.description.abstractFast-growing broilers faced with various leg health problems are in crucial need of an adequate nutritional supply of both calcium and phosphorus. The aim of the current work was to study the effect of different level of monocalcium phosphate supplementation on the health performance, haematology, and biochemistry changes of commercial broiler chickens. A total of 108 broiler birds (Cobb 500) were randomly divided into three treatment groups with six replicates consisting of six birds per replicates. Treatment 1 (control) was fed with available commercial starter and finisher diets containing dicalcium phosphate. Treatments 2 and 3 were fed with the same commercial diets but supplemented with 0.5% and 1.0% of monocalcium phosphate respectively. Throughout the 42 days of feeding trial, broilers from each treatment group were observed and recorded daily for any abnormal signs of leg disorders. Six broilers were randomly selected on days 21 and 42 from each treatment group where blood samples were collected via the brachial vein into anticoagulant (EDTA) and plain blood tubes for haematology and biochemistry analysis. Leg weakness, lameness, recumbency, and splay legs were the main findings observed in broiler demonstrating leg problems. The total broiler culled because of leg problem was relatively highest in T3 (4 broilers), followed by T1 (2 broilers), and T2 (none). There were significant differences (P ˂ 0.05) in the WBC, total protein, albumin, globulin, and alkaline phosphatase on day 21. Only WBC and alkaline phosphatase exhibited significant differences (P ˂ 0.05) between groups on day 42. Broilers supplemented with 0.5% MCP (T2) revealed the highest significant values compared to the other treatment groups for both starter and finisher phases. There were no significant differences (P > 0.05) in the other parameters. In summary, 0.5% monocalcium phosphate was recommended as supplementation through this study; as it improves the overall health performances of the commercial broiler chickens.en_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofComparative Clinical Pathologyen_US
dc.subjectPhytasesen_US
dc.subjectPhytic Aciden_US
dc.subjectInositol Phosphatesen_US
dc.titleHealth performance and blood profile changes in commercial broilers supplemented with dietary monocalcium phosphateen_US
dc.typeInternationalen_US
dc.identifier.doi10.1007/s00580-019-03085-9-
dc.description.page573-579en_US
dc.volume29(2)en_US
dc.description.typeArticleen_US
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeInternational-
crisitem.author.deptUniversity Malaysia Kelantan, Malaysia-
Appears in Collections:Faculty of Veterinary Medicine - Journal (Scopus/WOS)
Show simple item record

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.